Institute of Food Science, Technology and Nutrition (ICTAN), Spanish National Research Council (CSIC), C/José Antonio Novais 10, 28040 Madrid, Spain.
BMC Womens Health. 2014 May 30;14:71. doi: 10.1186/1472-6874-14-71.
Menstrual blood loss (MBL) has been shown to be an important determinant in iron status, work performance and well-being. Several methods have been developed to estimate MBL, the standard quantitative method however has limited application in clinical practice as it is expensive and requires women to collect, store and submit their sanitary products for analysis. We therefore aimed to develop a MBL-score based on a questionnaire, and to validate it by several hematological and biochemical parameters in women of childbearing age.
A total of 165 healthy young women were recruited. Hematological (hematocrit, hemoglobin, erythrocyte, leucocyte and platelet counts) and iron status (serum iron, serum ferritin, serum transferrin, and total iron binding capacity) parameters were analyzed at baseline. Women were asked to fulfill two gynecological questionnaires: a general questionnaire, to inform about the volunteer's general menstrual characteristics; and a MBL questionnaire, to provide details of the duration of menstruation, number of heavy blood loss days, and number and type of pads and/or tampons used during the heaviest bleeding day, for all consecutive menstrual periods during 16 weeks. A MBL-score was calculated for each period and women, and its reliability determined by the Cronbach's alpha coefficient. Pearson's linear correlation tests were performed between blood parameters and the MBL-score. Two clusters were formed according the MBL-score (cluster 1: low MBL and cluster 2: high MBL).
Significant higher MBL-score was observed in women who reported having a history of anemia (p = 0.015), staining the bed at night during menstruation (p < 0.001) and suffering inter-menstrual blood loss (p = 0.044), compared to those who did not. Women who used hormonal contraceptives presented lower MBL-scores than the others (p = 0.004). The MBL-score was negatively associated with log-ferritin (p = 0.006) and platelet count (p = 0.011). Women in cluster 1 presented higher ferritin (p = 0.043) than women in cluster 2.
We developed an easy and practical method for estimating menstrual blood loss based on a score calculated from a questionnaire in healthy women at childbearing age. The MBL-score is highly reliable and reflects menstrual blood loss validated by hematological and biochemical parameters.
月经失血量(MBL)已被证明是铁状态、工作表现和健康的重要决定因素。已经开发出几种方法来估计 MBL,但是标准的定量方法在临床实践中应用有限,因为它既昂贵又需要女性收集、储存并提交她们的卫生用品进行分析。因此,我们旨在开发一种基于问卷的 MBL 评分,并通过生育年龄妇女的几项血液学和生化参数对其进行验证。
共招募了 165 名健康年轻女性。在基线时分析血液学参数(血细胞比容、血红蛋白、红细胞、白细胞和血小板计数)和铁状态参数(血清铁、血清铁蛋白、血清转铁蛋白和总铁结合能力)。女性被要求填写两份妇科问卷:一份一般问卷,以告知志愿者的一般月经特征;一份 MBL 问卷,以提供 16 周内所有连续月经期间的月经期持续时间、大量出血天数、以及最大量出血日使用的护垫和/或卫生棉条的数量和类型的详细信息。为每个时期和女性计算 MBL 评分,并通过 Cronbach's alpha 系数确定其可靠性。对血液参数与 MBL 评分之间进行 Pearson 线性相关检验。根据 MBL 评分形成两个聚类(聚类 1:低 MBL,聚类 2:高 MBL)。
与没有报告贫血史(p=0.015)、月经期间夜间床染血(p<0.001)和月经间出血史(p=0.044)的女性相比,报告有此类情况的女性 MBL 评分明显更高。使用激素避孕药的女性 MBL 评分低于其他女性(p=0.004)。MBL 评分与 log 铁蛋白呈负相关(p=0.006)和血小板计数(p=0.011)。聚类 1 的女性铁蛋白水平高于聚类 2(p=0.043)。
我们开发了一种基于生育年龄健康女性问卷评分的估计月经失血量的简便实用方法。MBL 评分非常可靠,通过血液学和生化参数验证了月经失血量。